Category Archives: People

New Faces of Patient Advocacy

In this short video, Brianna Cayo-Cotter, Change.org’s managing director of communications, talks to Pharm Exec about how advocacy organizations and individual patients are getting more involved in every facet of the healthcare system, from drug R&D, to federal and state policy, all fueled by the hour-to-hour passion of living with a disease.
Also posted in E-Media, healthcare, patient education, social media, Video | Tagged , , | Leave a comment

HBA's 2014 Woman of the Year: Broadening the Base

HBA’s 2014 Woman of the Year:  Broadening the Base To mark its 25th year in recognizing female leadership in the tough competitive ranks of biopharma, the Healthcare Businesswomen’s Association [HBA] is opting for a breakout triple play.  When the group convenes on May 1 in New York for its annual Woman of the Year [WOTY] […]
Also posted in Events, healthcare, leadership | Tagged , , , , , | Leave a comment

The Changing Face of Patient Advocacy

Pleas for compassionate use access are on the increase, and Change.org is giving patients an audience. In THE ACTIVE PATIENT: FACES OF CHANGE, PharmExec’s feature story, Brianna Cayo-Cotter, Change.org’s managing director of communications, says one successful petition often begets another. Politicians and celebrities, in unprecedented fashion, are coming out in support of compassionate use petitions. […]
Also posted in healthcare, Patient Communication | Tagged , | Leave a comment

Compliance Congress: Walking the Line

Pharma industry executives, FDA officials and Department of Justice attorneys speaking last week at CBI’s 11th annual Pharmaceutical Compliance Congress (PCC) offered solutions and threats to companies hoping to avoid enforcement actions.
Also posted in Advertising, compliance, Emerging Markets, FDA, Global, Legal, Manufacturing, Marketing, Regulatory, Sales, Strategy, Technology | Tagged , , , , , , , , , , , , , | Leave a comment

Waxman Retirement, Tip of the Iceberg

The Washington health policy world is headed for a major shake-up next year, as more long-time leading legislators opt for retirement. The recent announcement that Rep. Henry Waxman (D-Calif) will leave marks the end of a 40-year career on Capitol Hill, highlighted by engineering enactment of legislation that established the generic drug industry, supported treatment […]
Also posted in FDA, healthcare, Regulatory, Strategy | Tagged , , | Leave a comment
  • Categories

  • Meta